Bodyweight Gain with Atypical Antipsychotics

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

1998 • 1,628 citations

Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors

1995 • 1,264 citations

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1996 • 1,143 citations

Prevalence of smoking among psychiatric outpatients

1986 • 1,059 citations

Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings

1997 • 985 citations

Weight, Weight Change, and Coronary Heart Disease in Women

1995 • 910 citations

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1997 • 906 citations

Olanzapine versus Placebo and Haloperidol

1996 • 788 citations

Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo

1997 • 756 citations

Double-Blind Comparison of Olanzapine Versus Risperidone in the Treatment of Schizophrenia and Other Psychotic Disorders

1997 • 722 citations

Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence

1998 • 719 citations

Olanzapine Versus Placebo in the Treatment of Acute Mania

1999 • 580 citations

Serotonin and appetite

1984 • 579 citations

Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol

1995 • 558 citations

Novel antipsychotics: comparison of weight gain liabilities.

1999 • 532 citations

Quetiapine in Patients With Schizophrenia

1997 • 487 citations

Novel antipsychotics and new onset diabetes

1998 • 416 citations

The Distribution of Body Mass Index Among Individuals With and Without Schizophrenia

1999 • 402 citations

Novel Antipsychotics

1999 • 389 citations

Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial

1996 • 387 citations

Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder A 6-Week Placebo-Controlled Trial

1999 • 387 citations

Mechanisms of action of atypical antipsychotic drugs: a critical analysis

1996 • 315 citations

Body weight gain induced by antipsychotic drugs: mechanisms and management

1999 • 311 citations

Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study

1992 • 302 citations

Risperidone Versus Clozapine in Treatment-Resistant Chronic Schizophrenia: A Randomized Double-Blind Study

1998 • 277 citations

Tolerability and therapeutic effect of clozapine

1985 • 277 citations

ICI 204,636, an Atypical Antipsychotic

1996 • 275 citations

Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial

1998 • 273 citations

A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia

1997 • 253 citations

Clozapine-induced weight gain: prevalence and clinical relevance

1992 • 250 citations

Olanzapine Increases Weight and Serum Triglyceride Levels

1999 • 231 citations

Body Weight and Leptin Plasma Levels During Treatment With Antipsychotic Drugs

1999 • 226 citations

Prevalence of Diabetes and Impaired Glucose Tolerance in Patients Treated With Clozapine Compared With Patients Treated With Conventional Depot Neuroleptic Medications

1998 • 220 citations

Olanzapine Treatment of Children, Adolescents, and Adults with Pervasive Developmental Disorders

1999 • 220 citations

Risperidone Treatment of Children and Adolescents With Pervasive Developmental Disorders: A Prospective, Open-Label Study

1997 • 214 citations

Clozapine decreases smoking in patients with chronic schizophrenia

1995 • 200 citations

Pharmacologic activation of limbic structures and neuroimaging studies of emotions.

1997 • 196 citations

Clozapine and Associated Diabetes Mellitus

1997 • 189 citations

A comparison of the effects of quetiapine (‘Seroquel’) and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment

2000 • 180 citations

Effects of clozapine on smoking in chronic schizophrenic outpatients.

1995 • 180 citations

Clozapine and weight gain.

1994 • 178 citations

Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations

1993 • 177 citations

The Role of Serotonin in Eating Disorders

1990 • 172 citations

Risperidone Treatment of Children and Adolescents with Chronic Tic Disorders: A Preliminary Report

1995 • 172 citations

Serum leptin levels increase rapidly after initiation of clozapine therapy

1998 • 169 citations

Carbohydrate craving in obese people: Suppression by treatments affecting serotoninergic transmission

1981 • 169 citations

Biochemical pharmacology of the anorectic drug fenfluramine: a review

1979 • 167 citations

Open-Label Quetiapine in the Treatment of Children and Adolescents with Autistic Disorder

1999 • 164 citations

Differential effect of clozapine on weight: a controlled study

1996 • 158 citations

A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, ‘Seroquel’) and haloperidol in schizophrenia

2000 • 150 citations

Weight gain among schizophrenic patients treated with clozapine

1992 • 144 citations

Weight Gain Associated With Neuroleptic Medication: A Review

1995 • 134 citations

Clinically significant side effects of lithium treatment A SURVEY OF 237 PATIENTS IN LONG‐TERM TREATMENT

1980 • 130 citations

Weight Gain

1999 • 126 citations

Prevalence of Obesity in Patients Receiving Depot Antipsychotics

1988 • 123 citations

Different Influences of Classical Antipsychotics and Clozapine on Glucose-Insulin Homeostasis in Patients With Schizophrenia or Related Psychoses

1999 • 123 citations

Randomized, Double-Blind, Controlled Trial of Risperidone Versus Clozapine in Patients With Chronic Schizophrenia

1995 • 122 citations

Risperidone and explosive aggressive autism.

1997 • 121 citations

Weight gain induced by clozapine

1995 • 117 citations

Fluoxetine's effect on weight loss in obese subjects

1991 • 115 citations

Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials.

1999 • 109 citations

Weight Gain in Adolescents Treated with Risperidone and Conventional Antipsychotics Over Six Months

1998 • 109 citations

An open clinical trial of risperidone monotherapy in young children with autistic disorder.

1997 • 100 citations

Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double‐blind parallel‐group trial

1995 • 99 citations

Double-blind Comparison of Risperidone and Haloperidol in Schizophrenic and Schizoaffective Psychoses

1993 • 99 citations

Olanzapine in treatment-resistant bipolar disorder

1998 • 98 citations

D2 and 5-HT2 receptor effects of antipsychotics: bridging basic and clinical findings using PET.

1999 • 92 citations

The Efficacy and Safety of Clozapine Versus Chlorpromazine in Geriatric Schizophrenia

1999 • 82 citations

Risperidone in the treatment of schizophrenia: a meta-analysis of randomized controlled trials

1997 • 79 citations

Induction of Obesity by Psychotropic Drugs

1987 • 77 citations

Weight gain associated with clozapine

1990 • 76 citations

A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.

1996 • 75 citations

Olanzapine versus haloperidol in the treatment of schizoaffective disorder

1999 • 71 citations

A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia

1998 • 70 citations

Too many chronic mentally disabled patients are too fat

1985 • 65 citations

Risperidone-Induced Hepatotoxicity in Children and Adolescents? A Chart Review Study

1999 • 61 citations

A Clinical Trial of the Efficacy and Acceptability of d-Fenfluramine in the Treatment of Neuroleptic-induced Obesity

1988 • 61 citations

Clozapine in the treatment of 121 out-patients

1989 • 57 citations

Towards the improvement of compliance

1997 • 57 citations

Weight Changes during Clozapine Treatment

1998 • 51 citations

Clinical and economic aspects of risperidone treatment in adults with mental retardation and behavioral disturbance.

1996 • 32 citations

Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)

1992 • 28 citations

Assessment of Changes in Both Weight and Frequency of Use of Medications for the Treatment of Gastrointestinal Symptoms Among Clozapine-Treated Patients

1995 • 27 citations

Weight Gain as a Predictor of Long Term Clozapine Efficacy

1996 • 19 citations

What Makes an Antipsychotic ‘Atypical’?

1997 • 15 citations

The effect of long-term antipsychotic treatment on the body weight of patients suffering from chronic schizophrenia: clozapine versus classical antipsychotic agents

1999 • 12 citations

[Body weight increase: a side effect of zotepin (Nipolept)?].

1996 • 8 citations

[Clozapine and refractory schizophrenia. Long-term prospective study of 20 patients].

1994 • 7 citations

Cited By (0)

No citing papers found in database